Host defense against viruses and intracellular parasites depends on effector CD8 + T cells, whose optimal clonal expansion, differentiation, and memory properties require signals from CD4 + T cells. Here, we addressed the role of dendritic cell (DC) subsets in initial activation of the two T cell types and their co-operation. Surprisingly, initial priming of CD4 + and CD8 + T cells was spatially segregated within the lymph node and occurred on different DCs with temporally distinct patterns of antigen presentation via MHCI versus MHCII molecules. DCs that co-present antigen via both MHC molecules were detected at a later stage; these XCR1 + DCs are the critical platform involved in CD4 + T cell augmentation of CD8 + T cell responses. These findings delineate the complex choreography of cellular interactions underlying effective cell-mediated antiviral responses, with implications for basic DC subset biology, as well as for translational application to the development of vaccines that evoke optimal T cell immunity.
INTRODUCTION
The induction of an adaptive immune response requires the interaction of several lymphoid and myeloid cell types. For the generation of cytotoxic T lymphocytes (CTL), initial activation of naive CD8 + T cells occurs via antigen-presenting cells (APC) that engage the antigen-specific T cell receptor (TCR) and other stimulatory surface receptors of these lymphocytes (Curtsinger and Mescher, 2010) . The critical MHCI molecules involved in TCR recognition by CD8 + T cells can be loaded with antigenic determinants by a direct antigen-presentation pathway involving cytosolic proteins or by a cross-presentation pathway, which is fueled by extracellular proteins (Kurts et al., 2010) . The latter is believed to play an essential role for pathogens that do not directly infect professional APC.
A second conventional T cell, the CD4 + helper T cell, is activated via antigen-presenting MHCII molecules. In distinction to the ligands involved in activation of CD8 + T cells, antigenic peptides presented by MHCII molecules are typically derived from extracellular proteins or intracellular proteins that are recycled from the cell surface (Germain, 1994) . These CD4 + T cells provide crucial soluble and membrane-associated signals to antigen-specific B lymphocytes, leading to effective adaptive humoral immunity (Crotty, 2014) . As with B cells and humoral responses, CD4 + T cells also provide molecular ''help'' to CTL, optimizing cellular immune responses by enhancing CD8 + T cell clonal expansion, differentiation, and survival . Although the functional parallel is clear, a conceptual problem in comparing CD4 + T cell help for humoral versus cellular responses in mouse models is that the interaction between CD4 + and CD8 + T cells cannot be direct, based on TCR engagement, as mouse CD8 + T cells do not express the necessary MHCII molecules to provide ligands for the CD4 + T cell TCR. This paradox was resolved by experiments showing that dendritic cells (DCs) serve as a platform to mediate communication between CD4 + and CD8 + T cells (Mitchison and O'Malley, 1987; Ridge et al., 1998 ). Both T cell subsets must interact with the same DC in an antigen-and TCR-dependent manner, meaning that the ''platform'' DC must present antigen to CD4 + and CD8 + T cells via both the MHCII and MHCI pathways, respectively (Bennett et al., 1997; Cassell and Forman, 1988) .
Given that naive lymphocytes specific for a given foreign antigen are rare, it has been argued that the likelihood of a (simultaneous, random) three-cell encounter is too low to be effective at driving the responses in question (Bevan, 2004) . This argument has been weakened by experiments showing that (1) a DC that had interacted with a CD4 + T cell could help a CD8 + T cell even after the CD4 + T cell was removed, removing the need for contemporaneous three-cell clustering (Ridge et al., 1998) and (2) DC-CD4 + T cell interactions lead to the production of the chemokines CCL3/4 that attract CD8 + T cells via CCR5 to the licensed DC optimizing rare cell contacts . The same intravital imaging methods that revealed such chemokine-mediated guidance also showed that, upon encounter with antigen-laden DCs, T cells arrest and initiate long-term interactions lasting for several hours (16-20 hr) (Bousso and Robey, 2003; Miller et al., 2002; Stoll et al., 2002) . This means that both CD4 + and CD8 + T cells would be substantially delayed in finding a common DC even with chemokine guidance. Furthermore, the past decade has seen an increasingly detailed parsing of dendritic cells into distinct subsets with specific localizations within secondary lymphoid tissues (Gerner et al., 2012; Kissenpfennig et al., 2005) , as well as the emergence of strong evidence for preferential presentation of antigen via MHCI and MHCII by different DC types (den Haan et al., 2000; Dudziak et al., 2007; Schnorrer et al., 2006) . Together, the dynamic considerations and the complexity of DC biology raise the crucial issue of when, where, and on which DC do CD4 + and CD8 + T cells become activated and communicate.
In light of these unresolved questions, the present study aimed to elucidate the spatial and temporal events that occur during CD4 + T cell augmentation of CD8 + T cells responses (''help'') and to reveal the location and identity of the DC subset ( To understand how CD8 + T cells and CD4 + T cells interact with DCs during the induction of robust cell-mediated immune responses, we used a model system of vaccinia virus (VV) infection that supports both direct and cross-presentation pathways and elicits a CD4 + help-dependent CD8 + T cell response (Norbury et al., 2001; Wiesel et al., 2010) . To allow for a timeresolved analysis of the cellular events, we initially carried out our experiments with the replication-deficient variant MVA (modified vaccinia virus Ankara). This attenuated virus produces a single round of infection with full expression of early and late viral antigens (Drexler et al., 2004) . 4 hr after intravenous (i.v.) infection of mice with MVA-GFP, we could detect infected DCs based on GFP expression. Phenotypic analysis of infected DCs revealed a comparable infection rate among CD8a + and CD11b + DCs in the spleen ( Figure 1A ). After infection with a recombinant virus that also expresses the ovalbumin-derived SIINFEKL determinant (MVA-NP-S-GFP), the infected DCs also presented virally expressed antigens via MHCI as quantified by antibody staining with clone 25.D1, which recognizes SIINFEKL bound to the mouse MHCI molecule H-2Kb. To test whether such directly infected DC could drive CD8 + T cell proliferation, we infected Kbm1 animals (Kbm1 is a mutant Kb unable to bind SIINFEKL) with MVA-OVA and MVA-OVA-Kb, respectively. In this experimental set-up, only MVA-OVA-Kb-infected DCs were able to present antigen and promote proliferation of OT-I cells (CD8 + ovalbumin-specific, TCR transgenic T cells), whereas non-infected or MVA-OVA-infected DC were unable to stimulate OT-I cell proliferation in culture ( Figure 1B ). This demonstrates that directly infected DCs present viral antigens and induce proliferation of antigen-specific CD8 + T cells ex vivo. In vivo, we could detect direct interactions between MVA-OVA-GFP-infected DCs and transferred OT-I lymphocytes shortly after infection using intravital two-photon microscopy (IVM) and analysis of stained lymph node (LN) sections (Movie S1 and Figure 1C ). Arrested T cells were typically seen at the subcapsular sinus (SCS) and formed clusters in the interfollicular area and the cortical ridge as previously reported (Hickman et al., 2008; Kastenmü ller et al., 2013) . Because both DC and macrophages populate the area in which we see clusters of OT-I cells early after infection, we depleted macrophages using clodronate liposomes or used additional DC-specific reporter animals (Figures S1A-S1C) and analyzed clusters shortly after MVA-OVA-GFP infection. These data also indicated that DCs are the predominant cellular targets of early antigen recognition by the OT-I cells.
To elucidate whether different infected DC subsets have a differential capacity to stimulate OT-I cells, we infected mice i.v., sorted splenic CD11b + or CD8a + DCs 8 hr later, and co-cultured the sorted cells with CFSE-labeled OT-I cells. At 72 hr post-coculture, we consistently observed similar proliferation of OT-I cells after co-incubation with either DC subset ( Figures 1D and  S1D ). CD8a + DCs substantially overlap with the XCR1 + DC subpopulation (Becker et al., 2014) . Therefore, to further test whether CD8a + DCs are required for activation of OT-I cells in vivo, we transferred OT-I cells into wild-type (WT) or XCR1-DTR animals (Yamazaki et al., 2013) , treated them with Diphtheria toxin (DTX) to deplete the XCR1 + DCs, infected the animals with MVA-OVA in the footpad (f.p.), and then analyzed the expression of the early activation markers CD69 and CD25 on OT-I cells in the draining lymph node (dLN) 12 hr later. We found that the early activation of OT-I cells was unaltered in the absence of XCR1 + DCs ( Figures 1E and 1F ). In contrast, we found a small but consistent reduction in the early activation of OT-II cells (CD4 + ) also specific for OVA but presented by MHCII molecules ( Figures 1E and 1F Figure S1 and Movie S1.
observed the migratory behavior of the transferred T cells in situ using IVM. As expected, we could readily detect arrested OT-I cells clustering around infected DCs. Surprisingly, however, OT-II cells did not co-arrest with their CD8 + T cell counterparts (Movie S2 and Figure 2A) . Instead, they migrated similarly to polyclonal CD4 + control T cells at around 10 mm/min ( Figure 2B ). Later after infection (8-12 hr), we were unable to detect OT-I/OT-II co-clusters using IVM (data not shown), although kinetic experiments with isolated cells recovered from these animals revealed that the majority of the OT-II cells were activated (CD69 hi ) ( Figure 2C ) and therefore were likely to have engaged antigen-rich APC by this time point. These findings suggested that OT-II cells might be activated in deeper areas of the LN that are not typically visualized using IVM. Therefore, we analyzed frozen LN sections to identify the location OT-I and OT-II cell co-clusters. In line with our IVM data, we found that OT-II cells did not accumulate and cluster in the SCS area in contrast to OT-I cells ( Figure 2D ), which were found in proximity to MVA-infected (GFP-expressing) cells. OT-II cells did not cocluster substantially with OT-I, showing only random colocalization with OT-I at frequencies similar to OVA antigen-unspecific polyclonal CD4+ T cells (Figures S2A and S2B) . To further assess this spatial separation of CD4 + and CD8 + T cells during initial antigen-dependent priming after viral infection, we analyzed spleen sections at similar time points. Again, we found a segregation of antigen-specific CD4 + and CD8 + T cells. OT-I cells were localized at the marginal zone in proximity to infected APC ( Figures S2C and S2D ). In contrast, OT-II cells remained in the white pulp, where they clustered and were activated by non-infected (GFP-negative) APC ( Figures  S2C and S2D ).
To determine whether the segregation of OT-I and OT-II cells during activation is a phenomenon related to their particular TCRs, we generated MVA-GP-Venus and analyzed a different TCR transgenic T cell pair specific for the lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) (Smarta/CD4 + , P14/ CD8 + ). Similar to our previous results, we found accumulation of antigen-specific CD8 + T cells (P14) around MVA-GP-Venusinfected DC while antigen-specific CD4 + T cells (Smarta) accumulated in the paracortex ( Figures 2E and S2E ). Smarta cells formed homogenous clusters in the paracortex of dLN that were only randomly intermixed with P14 cells, similar to nonspecific control cells (Figures 2F and 2G) . To further evaluate whether the observed separated activation of antigen-specific CD4 + versus CD8 + T cells is a more general feature of initial activation, we examined two additional experimental systems. As a first approach, we used recombinant adenovirus infections and found that OT-I cells translocated to the SCS and IFA to interact with directly infected APC, whereas OT-II cells remained in the paracortex where they were activated in an antigen-specific manner ( Figures S2F-S2I ). Second, we immunized mice with soluble OVA protein and LPS as adjuvant. Again, we found that activation of OT-I and OT-II cells is predominantly separated (Figures S2J-S2M and Movie S3). In summary, we conclude that the initial activation of antigen-specific CD4 + and CD8 + T cells is segregated and involves distinct DC in different locations within the lymph node or spleen.
Identification of DCs that Present Viral Antigen via both MHCI and MHCII Later after Infection
These findings were surprising in light of previous reports demonstrating that CD4 + help for CD8 + T cells occurs on a single DC co-presenting MHCI and MHCII antigens (Bennett et al., 1997; Cassell and Forman, 1988) and our prior studies showing how chemokines guide T cells to DCs co-presenting MHCI and MHCII ligands . One way to reconcile the present observations with these prior findings is to postulate that the licensing and/or the delivery of help occurs later during the course of infection. To examine this possibility, we transferred OT-I, OT-II, and polyclonal CD4 + T cells into mice that had been infected for 30 hr and analyzed the location of these transferred cells in LN sections 8 hr after transfer ( Figure 3A ). With this experimental setup, we could readily detect OT-I and OT-II cell co-clusters, while polyclonal CD4 + T cells showed an unbiased distribution ( Figure 3B ). When systematically comparing cellular positioning in the LN early (10 hr) versus late (38 hr) after infection, we found marked differences for OT-I cells and modest differences for OT-II cells ( Figure 3C ). This reflects the predominant activation of OT-I at the SCS/IFA early after infection (10 hr) versus the presence of antigen-bearing DCs in the paracortex at later time points (38 hr). These paracortical DCs were able to present antigen to and activate both OT-I and OT-II T cells, as indicated by the OT-I and OT-II T cells expressing activation markers in co-clusters surrounding such DCs ( Figure 3D ). Thus, later during infection, a common DC, positioned in the peripheral paracortex, presents antigen able to productively engage the TCR of both CD4 + and CD8 + T cells. Use of two experimental approaches to block DC migration (site removal, lymph vessel obliteration) revealed that migratory DCs were not required for the formation of OT-I/OT-II cell co-clusters during the late phase of infection (Figures S3A and S3B) . Additionally, Batf3 KO animals that lack migratory CD103 + DCs but only a fraction of LN resident CD8a + (XCR1 + ) DCs (Edelson et al., 2010) showed mixed OT-I/OT-II cell co-clusters, confirming that CD103 + migratory DCs were dispensable for the formation of such clusters ( Figure S3B ). It is important to note that the presence of clusters consisting of three different cell types (OT-I/OT-II/DC) does not necessarily mean that those ternary interactions occur or are necessary for delivery of help under physiological conditions, as in these experiments an artificially high number of precursor T cells was used to facilitate detection of the co-presenting DCs.
Non-infected Cross-presenting XCR1
+ DCs Are the Information-Transmission Platform for CD4 + and CD8
+ T Cells
Given that XCR1 + DCs were dispensable for early CD4 + and CD8 + T cell activation (Figure 1 ) but play a central role in immunogenic CTL priming (Shortman and Heath, 2010) , we hypothesized that these DCs might be involved in the CD4 + and CD8 + T cell co-clustering we observed above. To investigate this hypothesis, we first attempted to identify which DC subset presents antigen to OT-I cells at a late stage of infection. CD11b + and CD8a + DCs were sorted 30 hr after infection and co-cultured with CFSE-labeled OT-I cells. In contrast to the results obtained early (8 hr) after infection ( Figure 1D ), at this later time point, exclusively CD8a + (XCR1 + ) DCs induced OT-I cell proliferation ( Figures 4A, S4A , and S4B). To test whether this is due to the known propensity of this DC subset to cross-present antigen, we infected C57BL/6 and Kbm1 mice with MVA-OVA-Kb, sorted the CD8a + DC subset 30 hr later, and co-incubated these DCs with CFSE-labeled OT-I cells ( Figure 4B ). If direct antigen presentation was still occurring, directly infected Kbm1 DCs should still be able to drive OT-I cell proliferation due to virally driven Kb expression ( Figure 1B ). However, this was not the case, supporting the notion that, later during infection, at least when using replication-incompetent viruses, cross-presentation becomes the dominant pathway for MHCI loading with viral antigens. We then examined whether XCR1 + DCs also served as the platform that communicates with both antigen-specific CD4 + and CD8 + T cells in vivo. We infected XCR1-DTR-Venus mice, treated them with DTX or PBS, and transferred OT-I and OT-II cells into these animals 30 hr post-infection and DTX treatment. XCR1 + DCs were detected in the middle of mixed OT-I/OT-II cell co-clusters in PBS-treated animals 8 hr after T cell transfer (Figure 4C) . The XCR1 + DCs were not broadly distributed throughout the LN as in the steady state ( Figure S4C ) but rather formed aggregates that were intermixed with the co-clustered T cells (Figures 4C and S4D) . DTX depletion of XCR1 + DCs led to a loss of mixed OT-I/OT-II cell co-clusters, while leaving distinct OT-II and separate, rare OT-I cell clusters ( Figures 4C-4E ). We next quantified the requirement for XCR1 + DCs in the stimulation of OT-I
and OT-II cells at this late phase post-infection. 12 hr after T cell transfer, we harvested the dLN and analyzed OT-I and OT-II cells for CD69 expression using flow cytometry. In the absence of XCR1 + DCs, the fraction of activated OT-I cells dropped from 80% in WT to 15% in XCR1-DTR mice ( Figure 4F ). The activation of OT-II cells was modestly reduced from 60% to 40% if XCR1 + DCs were absent. Together, these data indicate that cross-presenting XCR1 + DCs serve as a platform for interaction (simultaneously or sequentially) with both antigen-specific CD4 + and CD8 + T cells at late times after infection.
XCR1 + DCs Are Also Critical for Communication between CD4
+ and CD8 + T Cells during Productive VV
Infection
We next examined whether these findings applied to events following infection with replication-competent VV that does not require antigen cross-presentation for T cell priming due to ongoing infection of DCs (Xu et al., 2010) . First, we addressed whether initial CD4 + and CD8 + T cell priming is also spatially separated during VV infection. To this end, we transferred OT-I and OT-II cells into WT animals and infected them with VV-OVA. IVM 10 hr p.i. confirmed the near-absolute separation of arrested OT-I and OT-II cells, with the former forming clusters near the LN capsule and the latter in deeper areas of the LN (Figure 5A and Movie S4). Similar to MVA-OVA infection, VV-OVA infection induced the accumulation of OT-I cells at the SCS, where they interacted with infected DC (Figures 5B, S5A , and S5B) (Hickman et al., 2011) . In contrast, OT-II cells remained in the paracortical areas of the LN and did not co-cluster with OT-I ( Figures 5B, S5C , and S5D). Next, we addressed whether late co-clustering of CD8 + and CD4 + T cells occurs after VV infection. Naive OT-I and OT-II cells were transferred into WT mice 30 hr post-infection, and the dLN were examined by fluorescent microscopy 8 hr later. Central sagittal sections showed that mixed T cell clusters consisted of activated (CD69 + ) cells in the peripheral paracortex rather than in the deep paracortical central region ( Figures 5C and  S5E ). Using VV-infected XCR1-DTR-Venus mice as recipients, we found that mixed OT-I/OT-II cell co-clusters were organized around XCR1 + DCs at this later time-point ( Figure S5F ). Depletion of XCR1 + DCs led to a loss of mixed OT-I/OT-II cell clusters, confirming that XCR1 + DCs are the predominant population involved in co-presentation of MHCI and MHCII determinants at this later stage, making them likely platforms for the delivery of help (Figures 5D-5F ). In the absence of XCR1 + DCs, OT-II cell clusters were still present in the paracortex, typically in proximity to the medullary area. OT-I cell clusters were also present albeit in lower frequency and, importantly, were separated from OT-II cells ( Figures 5E and 5F ). Persistent OT-I clusters in the absence of XCR1 + DCs reflect ongoing VV replication and continued infection of LN resident DCs. Such clusters were largely absent after infection with the replication-deficient in MVA ( Figures 3C and 3D ), most likely due to the absence of infected DCs at this time point. 
Localization of Endogenous

(legend continued on next page)
we found bright YFP + CD8 + cells in the paracortex ( Figure S6B ). Dim YFP + cells positioned in the paracortex were CD4 + , CD8 + , or double negative ( Figure S6C ). In contrast, YFP + NK cells were also dim but positioned at the SCS area rather than the paracortex ( Figures S6B and S6D ). Even at a 100-fold higher dose of VV-OVA (10 8 ), we did not observe cytokine-mediated activation of endogenous CD44 + CD8 + T cells, arguing that the identified enlarged, paracortical YFP + CD8 + T cells reflect previously activated antigen-specific T cells ( Figure S6E ). To determine whether the location of such endogenous activated CD8 + T cells corresponds to areas of the dLN in which we expect CD4 + T cell help to be delivered, we transferred OT-I cells as described in Figure 3A . Endogenous YFP + bright cells in the paracortex were CD69 negative or low and typically adjacent to clustered, transferred OT-I cells ( Figure 6F ). Examination of the distance between bright YFP + cells in the paracortex and the transferred activated OT-I cells revealed that the majority of those cells were closer than 20 mm ( Figure 6G ). These several observations are consistent with the view that the sequential model in which initial T cell priming occurs on distinct DC subsets in different LN regions-and subsequently, information exchange occurs on XCR1 + DCs as platform that co-presents antigen via both MHCI and MHCII molecules-applies not just to TCR transgenic models, but to polyclonal anti-viral responses as well.
VV-Specific T Cells Activated in the Absence of XCR1
+ DCs Are ''Helpless'' If the XCR1 + DC platform is dispensable for early CTL activation but important for later differentiation and survival of the activated CTL, XCR1 + DC depletion should negatively impact proliferation, effector differentiation, and memory CTL function, equivalent to the situation of CTL priming in the absence of CD4 + T cell help (Wiesel and Oxenius, 2012) . To test this prediction, we first analyzed the CD8 + T cell immune response on day (d)8 after VV infection in the presence or absence of CD4 + T cells. We found a significant reduction in the total number of antigen-specific CD8 + T cells in the spleen on d8 after infection ( Figure 7A) . A similar level of reduction in the immunodominant (B8R) CD8 + T cell response was also seen after depletion of XCR1 + DCs (Figure 7B ). Combined CD4 + T cell and XCR1 + DC depletion showed no additional reduction as compared to CD4 + T cell depletion alone, arguing that help is delivered via XCR1 + DCs ( Figure 7C ).
To see whether the observed reduction of the B8R-specific CD8 + T cell response upon XCR1 + DC depletion reflected the lack of help delivered via this DC population and not an unrelated function independent of antigen presentation to CD4 + T cells, we analyzed mixed BM (bone marrow) chimeric mice. MHCII KO x XCR1-DTR BM chimeric mice (50/50) were generated and infected with VV-OVA 8 weeks after reconstitution (Figures S7A and S7B) . In these animals, application of DTX results in a 50% depletion of XCR1 + DCs with the remaining XCR1 + DCs lacking expression of MHCII. Such MHCII-deficient DCs cannot serve as a platform for delivery of help ( Figure 7D ). The depletion of XCR1 + MHCII + DCs led to a significant reduction in the anti-viral B8R-specific CD8 + T cell response on d8 post-priming ( Figure 7E ). We further examined whether the absence of XCR1 + DCs impacts CD8 + T cell differentiation to an effector or memory state (Janssen et al., 2003; Shedlock and Shen, 2003; Sun and Bevan, 2003) . We found a striking shift toward terminally differentiated effector cells (CD127 À /KLRG1 + ) and a relative loss of memory precursors (CD127 + /KLRG1 À ) if XCR1 + DCs were depleted (Figure 7F ), along with a significant reduction in the capacity of the activated CD8 + T cells to produce IL-2 ( Figure 7G) . A similar loss in IL-2 producing cells was also observed when starting the depletion after infection (Figures S7C-S7E ). In contrast, the capacity of antigen-specific CD8 + T cells to produce IFNg appeared to be unaltered when comparing these conditions (Figure S7F) . Next, we analyzed the memory response in mice that were previously infected with VV-OVA in the presence or absence of XCR1 + DCs. Interestingly, we detected only a small but significant reduction in the total numbers of B8R multimerspecific CD8 + T cell in the memory phase if XCR1 + DCs were absent during priming ( Figure S7G ). However, analysis of memory subsets on d60 post-prime showed a significant increase in KLRG1 + B8R multimer-specific memory T cells if XCR1 + DCs were depleted during priming ( Figures 7H and 7I ). This memory subset was characterized by prominent CD127 expression typically seen in classical central memory T cells (CD127 hi / KLRG1 À ). The antigen-specific CD8 + memory T cells had a full capacity to produce IFNg if XCR1 + DCs were absent during priming ( Figure 7J ). Yet, these memory CD8 + T cells had a profound defect in IL-2 production ( Figure 7K ), which was characterized by a reduction of polyfunctional T cells (IFNg + TNFa + IL-2 + ) ( Figure 7K ) and a reduced amount of IL-2 production on a single-cell level as measured by the MFI ( Figure S7H ). Finally, to test the capacity of the memory cells generated in the absence or presence of XCR1 + DCs to undergo optimal secondary expansion, we rechallenged such mice with L. monocytogenes expressing the B8R peptide (Lm-B8R). 5 days after challenge, we found that mice that lacked XCR1 + DCs during the priming with VV-OVA failed to mount a robust recall response against LM-B8R ( Figure 7L ), providing a physiological relevance of XCR1 + DCs as a critical platform for delivery of cognate helper signals from CD4 + T cells.
DISCUSSION
Here, we report the spatio-temporal dynamics of CD4 + and CD8 + T cells early after viral infection and the role of distinct DC subpopulations in both activation of and communication between CD4 + and CD8 + T cells during this crucial phase of the adaptive immune response. Our data reveal a complex (C) Images of dLN using the experimental setup as in Figure 3A . XCR1-DTR-Venus mice were treated with PBS or DTX. (D and E) T cell cluster abundance in the presence or absence of XCR1 + DC using a (D) semi-automated or (E) fully automated analysis. + and CD8 + T cells, shaping the differentiation of the latter and modulating memory programming even in situations in which cross-presentation per se is not required. The finding that early CD4 + and CD8 + T cell activation postinfection is separated and orchestrated at distinct anatomical localizations was surprising. This feature may have been missed in previous studies because of an exclusive focus on the dynamic behavior of CD8 + T cells (Hickman et al., 2008 (Hickman et al., , 2011 Kastenmü ller et al., 2013) or the use of peptide-pulsed DC when co-analysis of both CD4 + and CD8 + behavior was studied (Beuneu et al., 2006; . Several reports previously showed a propensity of distinct DC subsets to present via either MHCI or MHCII molecules when using protein antigens (den Haan et al., 2000; Dudziak et al., 2007; Schnorrer et al., 2006) . Factors that regulate such differential antigen-presentation among DC subsets have been described (Dudziak et al., 2007; Vander Lugt et al., 2014) , and numerous viral immune evasion proteins that interfere with antigen-presentation have been identified (Alcami and Koszinowski, 2000) . However, the profound spatial segregation of CD4 + versus CD8 + T cell activation early after infection requires additional investigation to more fully understand the basis for this phenomenon and its relevance to the acute and memory phases of immunity. Given the preferential localization of DC subsets within subregions of the LN (Gerner et al., 2012; Kissenpfennig et al., 2005) , these new findings suggest a complex combination of intrinsic DC biology and pathogen-associated effects on antigen presentation and localization of DC subsets will greatly affect the nature of the ensuing cell-mediated response. It is unknown how many naive CD8 + T cells actually require signals derived from CD4 + T cells to mount a robust and functional memory CD8 + T cell response. In any given naive mouse repertoire of a few hundred CD8 + T cells specific for a foreign antigen, it might just be (the proliferative progeny of) a few initially activated T cells that receive functional ''help'' from CD4 + T cells. This quantitative issue places some limits on the interpretation of our results. Because we cannot directly visualize the specific subset of ''helped'' CD8 + T cells as they receive the necessary molecular signals, we cannot formally exclude the possibility that the relevant memory CD8 + T cell pool is formed by the offspring of a few T cells that do not correspond to the bulk behavior of the cells we quantify. Specifically, it is possible that a minor, but biologically relevant population of naive CD8 + T cells encounters a cross-presenting (helped) XCR1 + DC first rather than undergoing initial activation on a directly infected non-licensed DC as in our proposed model. Nonetheless, several lines of reasoning support the notion that CD4 + T cell help is primarily delivered to activated rather than naive CD8 + T cells. First, although CCR5 expression can occur in a TCR-independent manner, optimal upregulation of this chemokine receptor occurs upon antigen activation, giving the T cells the capacity to follow chemokine signals to the licensed DCs . Second, naive T cells interact for many hours with DCs that present high-potency foreign antigens. During this period (defined as phase II by Mempel et al. [2004] ), the DC-engaged CD8 + T cells would not be able to search for the optimal (licensed) DCs. After these long-lasting interactions, activated T cells enter a third phase that is characterized by short interactions with DCs (Mempel et al., 2004) . To date, the biological relevance of this third phase has remained elusive. Our model assigns it a potential specific biological function, namely the search for licensed DCs. Third, besides CD8 + T cells, CD4 + T cells also require pre-activation in order to express the molecules that are required to deliver help, in particular CD40 ligand (Bennett et al., 1998; Ridge et al., 1998; Schoenberger et al., 1998) . Finally, our new model reveals a close similarity between the cellular events that occur during CD4 + help for B cells and for CD8 + T cells. B cells and CD8 + T cells are activated separately from CD4 + T cell helpers at different anatomical locations before they come together for signal exchange (McHeyzer-Williams et al., 2006) .
Besides the implication that pre-activated rather than naive lymphocytes deliver/receive help, LN-resident XCR1 + DCs have been identified as the critical platform on which such signals are transmitted. Interestingly, migratory DCs seemed dispensable for initial CD8 + T cell activation or for provision of help. Vaccinia virus particles directly disseminate to the dLN after local intradermal infection of the skin (Lin et al., 2013) , in contrast to Herpes simplex virus that requires migratory DCs to shuttle antigen to the dLN (Bedoui et al., 2009) . With the latter virus, migratory DCs are required to hand off antigen to LNresident DCs (Allan et al., 2006) . This hand-off is in line with our work showing the crucial requirement of LN-resident XCR1 + DCs rather than migratory DCs to act as a critical platform to provide help to CD8 + T cells. (legend continued on next page)
The XCR1 + DC subset has primarily received attention due to its capacity to cross-present antigens (Shortman and Heath, 2010) . Our experiments have uncovered an important additional function by using a model that does not require cross-presentation for CD8 + T cell priming (Xu et al., 2010) . In this situation, the absence of XCR1 + DCs had a small effect on the primary immune response, compared to the absence of CD4 + T cell help. However, we found a profound role of XCR1 + DCs on the differentiation of CD8 + T cells and the functionality of the resulting memory T cells, which largely lacked the ability to produce the IL-2 needed for an optimal recall response (Feau et al., 2011 , and possibly others) operate in a staged, dynamic process to provide both early effectors and memory cells that later support host defense upon re-infection. In the context of previous findings on the contribution of chemokine signaling to optimization of communication involving T cell subsets and DCs Hickman et al., 2011; Hugues et al., 2007) and evidence for phased changes in T cell migratory dynamics after viral infection (Mempel et al., 2004) , we are now able to draw an increasing complete picture of how this limb of the adaptive immune system operates to enable rare cells to generate robust acute and memory responses. The new evidence for distinct roles of DC subsets in primary activation of CD4 + versus CD8 + T cells and as a platform for their communication also provides guidance for how to best direct vaccine components to drive specific aspects of immunity.
EXPERIMENTAL PROCEDURES Animals
Mice were purchased from Jackson or Janvier Labs or maintained at in-house facilities. All mice were maintained in specific pathogen-free conditions at an Association for Assessment and Accreditation of Laboratory Animal Careaccredited animal facility. All procedures were approved by the NIAID Animal Care and Use Committee (NIH) and the North Rhine-Westphalia State Environment Agency (LUA NRW), respectively. For details on mouse strains, see Supplemental Information.
Viruses, Bacteria, and Infections 10 7 -10 8 IU recombinant MVA, 10 6 À10 7 PFU VV-OVA, 2x 10 7 PFU Ad-OVA-GFP or 5x10 3 CFU LM-B8R were diluted in PBS and injected in the footpad (foothock [Kamala, 2007] ), i.v. or i.p.
Adoptive T Cell Transfer
OT-I, OT-II, P14, Smarta, or polyclonal control CD4 + T cells were purified using a MACS CD4-or CD8-negative selection kit (Miltenyi) combined with biotinylated anti-CD44 (IM7, BD Biosciences). 2-4310 6 cells were transferred i.v.
In Vitro Proliferation Assay OT-I cells were isolated and labeled with CFSE 5 mM (Invitrogen), followed by an ex vivo 72 hr co-incubation with isolated splenic DCs or LN-derived DCs.
Isolation of DC and Cell Sorting
Spleens or LNs were harvested and digested with Collagenase D/DNase for 30 min followed by a DC enrichment step using MACS CD11c-positive selection kit (Miltenyi) and sorting based on CD11c, MHCII, CD8, and CD11b staining using a FACSAria (BD Biosciences) cell sorter. Cellular purity was >95%.
Flow Cytometry
For analysis, LN and spleens were harvested and single-cell suspensions were generated. For details on antibodies, see Supplemental Information.
Immunofluorescence Staining PLP-fixed, frozen tissues were cut, stained, mounted, and acquired on a 710 confocal microscope (Carl Zeiss Microimaging). For details on antibodies, see Supplemental Information.
Intravital Two-Photon Imaging Mice were anesthetized, popliteal LNs were exposed, and intravital microscopy was performed using a protocol modified from a previous report (Kastenmü ller et al., 2013) . Raw imaging data were processed and analyzed with Imaris (Bitplane). For details, see Supplemental Information.
Analysis of Imaging Data
Images were systematically analyzed using a semi-automated (Imaris/ Bitplane) and a fully automated approach. For details, see Supplemental Information.
Statistical Analysis
Student's t test (two-tailed) and Mann-Whitney test were used for the statistical analysis of differences between two groups with normal and non-normal distribution.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, seven figures, and four movies and can be found with this article online at http://dx.doi.org/10.1016/j.cell.2015.08.004.
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